Home/Stocks/AGIO

AGIO

USD

Agios Pharmaceuticals Inc. Common Stock

$39.440+0.110 (0.280%)

Real-time Price

Healthcare

Biotechnology

United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$39.330

High

$40.320

Low

$38.900

Volume

0.19M

Company Fundamentals

Market Cap

2.3B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.65M

Exchange

NMS

Currency

USD

52-Week Range

Low $23.42Current $39.440High $62.58

Related News

Nov 3, 2025 · 02:01 PM

GlobeNewswire

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases,

Oct 30, 2025 · 10:30 AM

GlobeNewswire

Agios Reports Third Quarter 2025 Financial Results and Provides Business Update

$12.9 million in third quarter PYRUKYND® (mitapivat) net revenuesPDUFA goal date for PYRUKYND U.S. sNDA in thalassemia set for December 7, 2025CHMP adopted positive opinion for PYRUKYND in thalassemia; EC decision